Table 2.
Repurposed candidate drugs for AD identified using ESCARGOT on AlzKB. These drugs are novel repurposing candidate drugs as they have neither been used as treatments for Alzheimer’s disease nor reported in previous studies
| Drug | Filtering | DrugClass | AD Genes | ATC classification (Level 1) | ATC classification (Level 2) |
|---|---|---|---|---|---|
| Epirubicin | 2-hop Pathway | Anthracyclines Topoisomerase Inhibitors | IL1B, APOE | Antineoplastic and immunomodulating agents | Antineoplastic agents |
| Vemurafenib | 2-hop Pathway | Cytochrome P450 1A2 Inhibitors P-Glycoprotein Inhibitors Protein Kinase Inhibitors | CASP3, ADAM10 | Antineoplastic and immunomodulating agents | Antineoplastic agents |
| Vitamin A | 2-hop BodyPart | Vitamin A | DPYSL2, APP PPARG, HMOX1 | Sensory organs | Ophthalmologicals |
| Fulvestrant | 2-hop BodyPart | Estrogen Receptor Antagonists Selective Estrogen Receptor Modulators | WWOX, ESR1, HMOX1 | Antineoplastic and immunomodulating agents | Antineoplastic agents |